Yahoo Web Search

  1. Ad

    related to: neurodegenerative diseases

Search results

    • Clene (NASDAQ: CLNN) Issues Update on NIH-Funded Program for CNM-Au8(R) in ALS

      Digital Journal· 2 days ago

      ...: CLNN) (along with its subsidiaries, "Clene") and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, has announced several key updates on...